NeuroMetrix Stock News

The stock price of Neurometrix Inc (NASDAQ: NURO) increased by 173% during intraday trading. This is why it happened.

Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. The post NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors

NeuroMetrix Inc's (NASDAQ: NURO) Quell device has received Breakthrough Designation from the FDA to treat fibromyalgia symptoms in adults. Fibromyalgia is a common form of chronic pain accompanied

NeuroMetrix (NURO) stock is surging higher on Tuesday after getting "Breakthrough Device Designation" from the FDA for Quell. The post NURO Stock: The ‘Breakthrough' News Rocketing NeuroMetrix Share

NeuroMetrix Inc (NASDAQ: NURO) has reported that top-line results from a randomized controlled trial of Quell for fibromyalgia will be presented at two upcoming pain medicine conferences. Quell is

NeuroMetrix, Inc.'s (NURO) CEO Shai Gozani on Q1 2021 Results - Earnings Call Transcript

WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on A

NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript

WOBURN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company is focu

WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of t

NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. The stock's volume is currently 62.04 million, which is roughly 32668.92% of its recent 30-day volume average of 189.91 thousand.

NeuroMetrix (NURO) stock is on the rise Tuesday with heavy trading despite a lack of news concerning the medical device company. The post NURO Stock: 10 Things for Potential Investors to Know About Ne

Equities analysts forecast that Sensus Healthcare Inc (NASDAQ:SRTS) will announce ($0.13) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts hav

Oct 07, 2020 (Heraldkeepers) -- Global Keloid Treatment Market share consists of several players including Pacific World Corporation, Revitol Corporation...

Sep 25, 2020 (AB Digital via COMTEX) -- Smart Medical Devices Market 2020 A new report added to the online inventory of Wise Guys Reports (WGR) reveals that...